FDA Approves First CRISPR Gene Therapies for Sickle Cell Disease, Marking New Era in Medicine
Rapid Read

FDA Approves First CRISPR Gene Therapies for Sickle Cell Disease, Marking New Era in Medicine

What's Happening? In December 2023, the U.S. Food and Drug Administration (FDA) approved the first two cell-based gene therapies for sickle cell disease. One of these, exagamglogene autotemcel (exa-cel; Casgevy; Vertex Pharmaceuticals, CRISPR Therapeutics), is notable as the first FDA-approved thera
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.